Experimental drug offers hope for advanced cancers with no other options
NCT ID NCT07021066
Summary
This early-stage trial is testing a new drug called BL-M05D1 in people with advanced cancers that have spread and stopped responding to standard treatments. The study will enroll 120 patients with specific cancers like stomach, pancreatic, and esophageal cancer to determine the safest dose and see if the drug shows any effectiveness. This is the first time this experimental treatment is being given to humans, so the main focus is on safety and how the body processes the drug.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED PANCREATIC DUCTAL ADENOCARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Baylor Scott and White Medical Center- Temple Clinic
NOT_YET_RECRUITINGTemple, Texas, 76504, United States
Contact Email: •••••@•••••
Contact
-
Hackensack University Medical Center
NOT_YET_RECRUITINGHackensack, New Jersey, 07601, United States
Contact
Contact Email: •••••@•••••
-
HonorHealth
NOT_YET_RECRUITINGScottsdale, Arizona, 85266, United States
Contact Email: •••••@•••••
Contact
-
Karmanos Cancer Institute
NOT_YET_RECRUITINGDetroit, Michigan, 48201, United States
Contact Email: •••••@•••••
Contact
-
MD Anderson
NOT_YET_RECRUITINGHouston, Texas, 77030, United States
Contact
Contact Email: •••••@•••••
-
Mayo Clinic Cancer Center- Phoenix
NOT_YET_RECRUITINGPhoenix, Arizona, 85054, United States
Contact
Contact Email: •••••@•••••
-
Memorial Sloan Kettering Cancer Center
NOT_YET_RECRUITINGNew York, New York, 10065, United States
Contact
Contact Email: •••••@•••••
-
NEXT Oncology San Antonio
RECRUITINGSan Antonio, Texas, 78229, United States
Contact
Contact Email: •••••@•••••
-
NEXT Oncology- Austin
RECRUITINGAustin, Texas, 78758, United States
Contact Email: •••••@•••••
Contact
-
NEXT Oncology- Dallas
RECRUITINGDallas, Texas, 75039, United States
Contact
Contact Email: •••••@•••••
-
Ochsner Medical Center
NOT_YET_RECRUITINGNew Orleans, Louisiana, 70121, United States
Contact Email: •••••@•••••
Contact
-
START Center for Care Center- San Antonio
NOT_YET_RECRUITINGSan Antonio, Texas, 78229, United States
Contact
Contact Email: •••••@•••••
-
Sarah Cannon Research Institute - Oncology Partners
RECRUITINGNashville, Tennessee, 37203, United States
Contact
Contact Email: •••••@•••••
-
University of Colorado Health
NOT_YET_RECRUITINGAurora, Colorado, 80045, United States
Contact Email: •••••@•••••
Contact
-
University of Michigan
NOT_YET_RECRUITINGAnn Arbor, Michigan, 48109, United States
Contact Email: •••••@•••••
Contact
-
Vanderbilt-Ingram Cancer Center
NOT_YET_RECRUITINGNashville, Tennessee, 37232, United States
Contact
Contact Email: •••••@•••••
-
Yale Cancer Center
NOT_YET_RECRUITINGNew Haven, Connecticut, 06510, United States
Contact
Contact Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.